| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/23/2004 | US6709864 Composition comprising isolated human mesenchymal stem cells in biocompatible matrix which supports differentiation and maturation of stem cells into adipocytes |
| 03/23/2004 | US6709831 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof |
| 03/23/2004 | US6709682 Palatability agent, an herbal phytochemical and a metabolic precursor act synergistically to increase blood circulation, enhancing transport of said phytochemical and metabolic precursor to an affected site |
| 03/23/2004 | US6709676 Bilayer solid comprising an immediate release first layer of desloratadine, and an antioxidant or group 2a or aluminum salts and excipient, and a sustained release second layer of nasal decongestant such as pseudoephedrine sulfate |
| 03/23/2004 | US6709675 Prevents leakage between capsule parts |
| 03/23/2004 | US6709674 Injectable pamidronate disodium |
| 03/23/2004 | US6709670 Containing mucosal stimulant; rapid, efficient oral or nasal mucosa adsorption; quickens recovery from fatigue |
| 03/23/2004 | US6709668 Hydrogel-forming system with hydrophobic and hydrophilic components |
| 03/23/2004 | US6709664 Administering selegiline, or metabolite thereof |
| 03/23/2004 | US6709663 Topical emulsion; quaternary ammonium salt emulsifier |
| 03/23/2004 | US6709660 Meningococcal antigens |
| 03/23/2004 | US6708822 Compositions and kits for compounding pharmaceuticals |
| 03/23/2004 | CA2519037A1 Treatment of proliferative diseases with epothilone derivatives and radiation |
| 03/23/2004 | CA2350074C Aerosols comprising nanoparticle drugs |
| 03/23/2004 | CA2283739C Ascorbic acid as an adjuvant in treatment of malignant tumors by chemotherapy and radiotherapy |
| 03/23/2004 | CA2263319C Quinazoline derivatives and pharmaceutical compositions containing them |
| 03/23/2004 | CA2180535C A method for treatment of psoriasis, by omeprazole or related compounds |
| 03/23/2004 | CA2168432C Piperazine compounds used in therapy |
| 03/23/2004 | CA2101575C New cycloalkylalkylamines which are sigma-receptor ligands, process for preparing them and their application in therapy |
| 03/20/2004 | CA2406504A1 Method of treating resistant tumors |
| 03/19/2004 | CA2400254A1 Compositions and methods for treating heart disease |
| 03/18/2004 | WO2004023340A2 Non-psychotropic cannabinoids for prevention of cognitive impairment |
| 03/18/2004 | WO2004022782A2 Compositions and methods for tissue specific or inducible inhibition of gene expression |
| 03/18/2004 | WO2004022775A1 Method and probe for identifying bacterial virulence modifying agents, agents thus identified, and their use |
| 03/18/2004 | WO2004022771A2 Short interfering nucleic acid hybrids and methods thereof |
| 03/18/2004 | WO2004022768A1 Arachidonic acid metabolites and modulation of mitosis and apoptosis of cells |
| 03/18/2004 | WO2004022761A1 Retroviral vector and stable packaging cell lines |
| 03/18/2004 | WO2004022750A1 Novel diagnostic and therapeutic methods and reagents therefor |
| 03/18/2004 | WO2004022749A1 Decoy-oligonucleotide-inhbition of cd40-expression |
| 03/18/2004 | WO2004022716A2 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 03/18/2004 | WO2004022699A2 Liquid stable composition of oxazaphosphorine with mesna |
| 03/18/2004 | WO2004022629A2 Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid |
| 03/18/2004 | WO2004022602A1 Highly branched, unsubstituted or low-substituted starch products, dialysis solution and plasma expander containing the same, and the use thereof |
| 03/18/2004 | WO2004022573A2 Adenosine a3 receptor agonists |
| 03/18/2004 | WO2004022572A1 Compounds that interact with kinases |
| 03/18/2004 | WO2004022569A1 Akt inhibitors, pharmaceutical compositions, and uses thereof |
| 03/18/2004 | WO2004022557A1 Novel benzonaphthyridines |
| 03/18/2004 | WO2004022556A1 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonist |
| 03/18/2004 | WO2004022553A1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING IκB KINASE |
| 03/18/2004 | WO2004022550A1 Compound for treatment of anxiety and methods of preparation and use thereof |
| 03/18/2004 | WO2004022543A1 Preventive and/or therapeutic drugs for inflammatory intestinal diseases |
| 03/18/2004 | WO2004022538A1 Crystal for oral solid drug and oral solid drug for dysuria treatment containing the same |
| 03/18/2004 | WO2004022533A1 Novel vinyl carboxylic acid derivatives and their therapeutical use |
| 03/18/2004 | WO2004022529A2 Diarylurea derivatives and their use as chloride channel blockers |
| 03/18/2004 | WO2004022526A1 Cathepsin cysteine protease inhibitors |
| 03/18/2004 | WO2004022525A1 Amide derivatives and their use as chloride channel blockers |
| 03/18/2004 | WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 03/18/2004 | WO2004022521A1 Optically active 1-(fluoro-,trifluoromethyl-or trifluoromethoxy-substituted phenyl)alkylamine n-monoalkyl derivatives and process for producing same |
| 03/18/2004 | WO2004022163A1 Neoadjuvant treatment of breast cancer |
| 03/18/2004 | WO2004022152A2 Radiotherapy method using x-rays |
| 03/18/2004 | WO2004022128A2 Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 03/18/2004 | WO2004022124A1 Medical device having hydration inhibitor |
| 03/18/2004 | WO2004022123A1 Coated stent |
| 03/18/2004 | WO2004022102A2 Pharmaceutical formulation with non-steroidal antiphlogistic agents and nucleic acids for the internalization of nucleic acids into eucaryotic cells |
| 03/18/2004 | WO2004022100A1 Soild nano pharmaceutical formulation and preparation method thereof |
| 03/18/2004 | WO2004022099A2 Cyclodextrin-based polymers for delivering the therapeutic agents covalently bound thereto |
| 03/18/2004 | WO2004022090A1 A method of modulating endothelial cell activity |
| 03/18/2004 | WO2004022089A1 Minibrain homologous proteins involved in the regulation of energy homeostasis |
| 03/18/2004 | WO2004022083A1 A nutritional and therapeutic composition of an insulin sensitizer and a peptide fraction |
| 03/18/2004 | WO2004022082A1 Embryo implantation inhibitor |
| 03/18/2004 | WO2004022076A1 Branched alpha-glucans for weight management |
| 03/18/2004 | WO2004022075A1 Treatment of neurological disorders by dsrna adminitration |
| 03/18/2004 | WO2004022074A1 Nutritional compositions comprising a non-glucose carbohydrate or pectin and soluble fiber |
| 03/18/2004 | WO2004022072A1 Boronic acid salts ant their use in the treatment of thrombosis |
| 03/18/2004 | WO2004022071A1 Multivalent metal salts of boronic acids for treating thrombosis |
| 03/18/2004 | WO2004022070A1 Boronic acid salts useful in parenteral formulations for selective thrombin inhibition |
| 03/18/2004 | WO2004022069A1 Delivery of modulators of glutamate-mediated neurotransmission to the inner ear |
| 03/18/2004 | WO2004022068A1 A method of extending the dose range of vitamin d compounds |
| 03/18/2004 | WO2004022067A1 Semi-solid skeleton composition of mifepristone |
| 03/18/2004 | WO2004022066A2 Method and means for the treatment of vascular and cardiac diseases |
| 03/18/2004 | WO2004022065A1 Pharmaceutical application of 15- or 16- substituted testosterone analogues |
| 03/18/2004 | WO2004022064A1 Methods of treatment of male erectile dysfunction |
| 03/18/2004 | WO2004022063A1 Transparent eye drops containing latanoprost |
| 03/18/2004 | WO2004022061A1 Use of indolyl derivatives for the manufacture of a medicament for the treatment allergic rhinitis |
| 03/18/2004 | WO2004022060A2 (1h-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine h4-receptor antagonists for the treatment of inflammatory and allergic disorders |
| 03/18/2004 | WO2004022059A2 Use of 6 amino-quinoline-5, 8 quinones and nucleic acids associated with senescence for the treatment of tumors |
| 03/18/2004 | WO2004022058A1 Inhalation medicaments containing a novel anticholinesterase drug in conjunction with corticosteroids and betamimetic drugs |
| 03/18/2004 | WO2004022057A1 USE OF IκB KINASE INHIBITORS FOR THE TREATMENT OF PAIN |
| 03/18/2004 | WO2004022056A1 Medicinal composition and method for treating malignant tumor and utilization thereof |
| 03/18/2004 | WO2004022054A1 Pyrazolopyridines and methods of making and using the same |
| 03/18/2004 | WO2004022052A1 Aerosol formulation for inhalation containing an anticholinergic agent |
| 03/18/2004 | WO2004022051A1 Peroxisome proliferator-activated receptor controllers |
| 03/18/2004 | WO2004022050A1 Agents, foods and drinks controlling lipid metabolism |
| 03/18/2004 | WO2004022049A1 Slimming agents and foods and drinks comprising the same |
| 03/18/2004 | WO2004022048A1 Fosfomycin and n-acetylcysteine for the treatment of biofilms caused by escheric ia coli and other pathogens of the urinary tract |
| 03/18/2004 | WO2004022047A1 USE OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA (PPAR $f(a)) AGONIST FOR THE TREATMENT OF CARNITINE PALMITOYL TRANSFERASE-2 DEFICIENCIES |
| 03/18/2004 | WO2004022046A1 Composition and method for treating skin |
| 03/18/2004 | WO2004022045A1 Hypogastric and/or perineal pain-relieving agent |
| 03/18/2004 | WO2004022044A1 Use of a combination of a taxane with dppe for the treatment of cancer |
| 03/18/2004 | WO2004022043A1 Use of a sri and vitamin b6 for the treatment of neurological and mental disorders |
| 03/18/2004 | WO2004022042A1 Effect of vitamin a gel on paranasal sinus mucosal regeneration |
| 03/18/2004 | WO2004022041A2 Treatment of non-allergic rhinitis by means of selective phosphodiesterase-4 inhibitors |
| 03/18/2004 | WO2004022040A2 Treatment of metastatic breast cancer with anthracyclines, taxanes and an histamine antagonist |
| 03/18/2004 | WO2004022039A2 Use of guanosine or inosine as anti-apoptotic agents in the treatment of i. a. neurodegenerative diseases or injuries at the nervous system |
| 03/18/2004 | WO2004022036A1 Block copolymer micelle composition having an enhanced drug-loading capacity and sustained release |
| 03/18/2004 | WO2004022035A1 Water stabilized medicinal aerosol formulation related applications |
| 03/18/2004 | WO2004022034A1 Dermatological preparation for the treatment of skin lesions |
| 03/18/2004 | WO2004022032A2 Pharmaceutical dosage form comprising a sulfite compound |
| 03/18/2004 | WO2004022026A1 Composition and use thereof as a pharmaceutical or cosmetic formulation for external application |
| 03/18/2004 | WO2004022023A1 Repair of dna mutagenic damage |